Flawed GVK studies: EMA sticks with suspension as firm fights on
This article was originally published in Scrip
Executive Summary
There appears to be no respite yet, for GVK Biosciences, the Indian contract research organization in the eye of a storm over allegations of data manipulation by European regulators.